Tumor-Associated Factors Are Enriched in Lymphatic Exudate Compared to Plasma in Metastatic Melanoma Patients

Journal of Experimental Medicine - United States
doi 10.1084/jem.20181618
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Plasma Markers for Identifying Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Clinical Cancer Research
Cancer ResearchOncology
2007English

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Angiopoietin-2 Levels Are Associated With Disease Progression in Metastatic Malignant Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma

Case Reports in Oncological Medicine
Oncology
2017English

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

Oncotarget
Oncology
2015English

Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy